Sort by
Unlocking Drug Stability: A Statistical Insight Across Accelerated, Intermediate, and Real-Time Conditions
Yassine Hameda Benchekroun,
Meriem Outaki
Background/Objectives: The stability of pharmaceutical compounds is a critical quality attribute; it is an essential step in the drug development process. Significant focus is required to understand the variation of quality pharmaceutical compounds under prevailing environmental storage conditions. Simultaneously, many issues arise in understanding updated regulations, knowledge of data sciences, and appreciation of common practices, presenting a challenge for defining a retest period and in predicting a prolongation of the shelf life of drug products. The purpose of this paper is to conduct a statistical study to assess stability and to forecast a prolongation of drugs shelf-life. Methods: A case study is suggested to identify the most appropriate statistical test for assessing stability. The results of physical and chemical tests are considered to detect changes and variability during different conditions (accelerate, intermediate and real). Results: In the stability study, minimal variability in the content of the substance of interest was obtained using the predictive interval approach over a period of 31 months, and an interval of ±1,2%. Conclusion: The example of the statistical study is given to provide different perspectives on statistical approaches for market approval.
Background/Objectives: The stability of pharmaceutical compounds is a critical quality attribute; it is an essential step in the drug development process. Significant focus is required to understand the variation of quality pharmaceutical compounds under prevailing environmental storage conditions. Simultaneously, many issues arise in understanding updated regulations, knowledge of data sciences, and appreciation of common practices, presenting a challenge for defining a retest period and in predicting a prolongation of the shelf life of drug products. The purpose of this paper is to conduct a statistical study to assess stability and to forecast a prolongation of drugs shelf-life. Methods: A case study is suggested to identify the most appropriate statistical test for assessing stability. The results of physical and chemical tests are considered to detect changes and variability during different conditions (accelerate, intermediate and real). Results: In the stability study, minimal variability in the content of the substance of interest was obtained using the predictive interval approach over a period of 31 months, and an interval of ±1,2%. Conclusion: The example of the statistical study is given to provide different perspectives on statistical approaches for market approval.
Posted: 14 November 2025
Vibrational Spectra of R and S Methyl Para Tolyl Sulfoxide and Their Racemic Mixture in the Solid, Liquid State and in Water Solution
Flaminia Rondino,
Mauro Falconieri,
Serena Gagliardi,
Mauro Satta,
Susanna Piccirillo,
Enrico Bodo
Posted: 14 November 2025
Tensile Strain Effect on Thermoelectric Properties in Epitaxial CaMnO3 Thin Films
Ebenezer Seesi,
Mohammad El Loubani,
Habib Rostaghi Chalaki,
Avari Suber,
Caden Kincaid,
Dongkyu Lee
Posted: 14 November 2025
Mechanistic Fingerprints from Chloride to Iodide: Halide vs. Ammonia Release in Platinum Anticancer Complexes
Lorenzo Chiaverini,
Luca Famlonga,
Davide Piroddu,
Matteo Pacini,
Riccardo Di Leo,
Emma Baglini,
Damiano Cirri,
Tiziano Marzo,
Diego La Mendola,
Alessandro Pratesi
+5 authors
Posted: 14 November 2025
Novel Core-Shell Nanostructure of ε-Poly-L-Lysine and Polyamide-6 Polymers for Reusable and Durable Antimicrobial Function
Saloni Purandare,
Rui Li,
Chunhui Xiang,
Guowen Song
Posted: 14 November 2025
Design, Synthesis, and Acetylcholinesterase Inhibitory Activity of Novel Oxytocin Analogs as Potential Therapeutics for Alzheimer’s Disease
Chhanda Charan Danta,
Adel Nefzi
Oxytocin (OXT) has demonstrated potential therapeutic effects in Alzheimer’s disease (AD) through mechanisms such as reducing amyloid-β (Aβ) accumulation and tau deposition, as well as exerting antioxidant and anti-inflammatory properties. A recent study further revealed that OXT can decrease acetylcholinesterase (AChE) activity in liver and kidney tissues, suggesting that its effects on Aβ and tau pathology may be mediated, at least in part, through AChE inhibition. Based on this rationale, a series of OXT derivatives were designed, synthesized, and evaluated using protein-protein interaction analysis, molecular docking, in vitro AChE inhibition assays, enzyme kinetics, and antioxidant assays. Docking and protein-protein interaction studies showed that OXT and its analogues fit well within the 20 Å gorge of the AChE active site, engaging both the catalytic active site (CAS) and the peripheral anionic site (PAS). In vitro AChE inhibition assays revealed promising activity, with OXT (Cmpd.16) and analogue 7 (Cmpd.7) exhibiting IC₅₀ values of 8.5 µM and 3.6 µM, respectively. Kinetic analysis determined inhibition constants (Kᵢ) of 45 µM for Cmpd.16 and 6 µM for Cmpd.7, with both compounds following a mixed-type inhibition mechanism. Furthermore, antioxidant evaluations indicated potential neuroprotective properties. In conclusion, OXT analogues act as dual-binding site AChE inhibitors, as supported by docking, protein-protein interaction, and kinetic analyses, and display greater inhibitory activity than OXT itself. These findings suggest that OXT analogues represent promising candidates for further development as AChE inhibitors for AD therapy.
Oxytocin (OXT) has demonstrated potential therapeutic effects in Alzheimer’s disease (AD) through mechanisms such as reducing amyloid-β (Aβ) accumulation and tau deposition, as well as exerting antioxidant and anti-inflammatory properties. A recent study further revealed that OXT can decrease acetylcholinesterase (AChE) activity in liver and kidney tissues, suggesting that its effects on Aβ and tau pathology may be mediated, at least in part, through AChE inhibition. Based on this rationale, a series of OXT derivatives were designed, synthesized, and evaluated using protein-protein interaction analysis, molecular docking, in vitro AChE inhibition assays, enzyme kinetics, and antioxidant assays. Docking and protein-protein interaction studies showed that OXT and its analogues fit well within the 20 Å gorge of the AChE active site, engaging both the catalytic active site (CAS) and the peripheral anionic site (PAS). In vitro AChE inhibition assays revealed promising activity, with OXT (Cmpd.16) and analogue 7 (Cmpd.7) exhibiting IC₅₀ values of 8.5 µM and 3.6 µM, respectively. Kinetic analysis determined inhibition constants (Kᵢ) of 45 µM for Cmpd.16 and 6 µM for Cmpd.7, with both compounds following a mixed-type inhibition mechanism. Furthermore, antioxidant evaluations indicated potential neuroprotective properties. In conclusion, OXT analogues act as dual-binding site AChE inhibitors, as supported by docking, protein-protein interaction, and kinetic analyses, and display greater inhibitory activity than OXT itself. These findings suggest that OXT analogues represent promising candidates for further development as AChE inhibitors for AD therapy.
Posted: 13 November 2025
Preparation, Characterization, and Catalytic Performance of Metal-Based Heterogeneous Catalysts for Glucose Oxidation to Gluconic Acid
Stamatia A. Karakoulia,
Asimina A. Marianou,
Chrysoula M. Michailof,
Angelos Lappas
Posted: 13 November 2025
Synthesis of Bioconjugation Reagents for Use in Covalent Cross-Linking of Proteins by Azide–Alkyne Cycloaddition
Nadja Suhorepec,
Luka Ciber,
Uroš Grošelj,
Nejc Petek,
Bogdan Štefane,
Marko Novinec,
Jurij Svete
Posted: 13 November 2025
Lavender Paper: A Sustainable Alternative for Pulp Production
Kateřina Hájková,
Josef Bárta,
Tomáš Holeček,
Michaela Filipi,
Jiří Synek
Posted: 13 November 2025
DFT Calculation of the Electronic Properties of Cubic Ti3Sb Crystals with Adsorbed and/or Partially Substituted Nitrogen
Mirsalim M. Asadov,
Solmaz Nariman Mustafaeva,
Saida Oktay Mammadova
Posted: 13 November 2025
Fast Catalytic Pyrolysis of Tamarind Pulp over Green HZSM-5 Zeolite
Dirléia dos Santos Lima,
Lucas Capello,
Manuela de Santana Santos,
Maria do Carmo Rangel
Posted: 13 November 2025
Impact of the Reducing Agent on the Cytotoxicity and Selectivity Index of Silver Nanoparticles in Leukemia and Healthy Cells
Jovani Guadalupe Aguirre León,
Belkis Coromoto Sulbarán Rangel,
Edsaul Emilio Pérez Guerrero,
Antonio Topete Camacho,
Trinidad García Iglesias,
Pedro Ernesto Sánchez Hernández,
Moises Ramos Solano,
Andrea Carolina Machado Sulbaran
Posted: 12 November 2025
“Sweet and Horny”: Biological Activities of the Annonaceae Family
Renata P. B. Menezes,
Natália F. de Sousa,
Diégina A. Fernandes,
Chonny Herrera-Acevedo,
Zoe L. Sessions,
Luciana Scotti,
Eugene N. Muratov,
Marcus Tullius Scotti
Posted: 12 November 2025
(7aR*,7bR*)-7a,7b-Dihydro-15Н-dibenzo[f,f’]cyclopenta[1,2-b:5,4-b’]dichromene
Dmitry V. Osipov,
Oleg P. Demidov,
Vitaly A. Osyanin
Posted: 12 November 2025
The Impact of Plasma Nitriding Bias Voltages on Mechanical Characteristics of 25 Cr2Ni4W Steel
Ouafa Hamidane,
Brahim Chermime,
Alim Mouhamed Mounes,
Mamoun Fellah,
Susana Devesa
Posted: 12 November 2025
Percentage of Gutta-Percha-Filled-Areas in Canals Obturated by Two Different Core Techniques with Endodontic Bioceramics Sealer
Antonio Libonati,
Danilo Marroni,
Giulio Barbalace,
Giulia Campanella,
Vincenzo Campanella
Posted: 12 November 2025
Investigated the Sound Absorption Performance of Wood-Based Sandwich Panels with Reinforced BFRP, GFRP, and Jute Fabric
Abdurrahman Karaman,
Hikmet Yazıcı
Posted: 12 November 2025
Application of a Low-Cost Fluorescence Detector for 3D Printed Lab on a Chip Microdevices
Mathias Stahl Kavai,
José Alberto Fracassi da Silva
Posted: 12 November 2025
Systematic Trends in the Melting Temperature and Composition of Eutectic Binary Mixtures with One Component from a Homologous Series
Harald Mehling
Posted: 11 November 2025
Aluminium Diffusion in the Copper-Based Alloy CuCr1Zr as an Electrode for Resistance Spot Welding
Jochen Junge,
Sascha Brechelt,
Henning Wiche,
Volker Wesling,
Harald Schmidt
Posted: 11 November 2025
of 400